Daniel Pharand
Directeur/Membre du Conseil chez CX One, Inc.
Profil
Daniel Pharand is currently a Director at CX One, Inc. He previously held positions such as President, Chief Executive Officer, CFO & Director at C Level III, Inc., Chief Executive Officer at Hemodynamic Therapeutics, Inc., Chairman at Arura Pharma, Inc., Chairman at Nevada Exploration, Inc., Director at Corautus Genetics, Inc., Director at Aurelian Resources, Inc., Director at Mistral Pharma, Inc., Director at Canadian Oil Recovery & Remediation Enterprises Ltd., Fund Manager at PricewaterhouseCoopers LLP, Chief Financial Officer at Cato Research LLC, Vice President at Innovatech Montreal, Inc., Principal at Cato BioVentures, and Chief Executive & Financial Officer at Cancer Advances, Inc. He has undergraduate degrees from McGill University and Concordia University.
Postes actifs de Daniel Pharand
| Sociétés | Poste | Début |
|---|---|---|
CX One, Inc.
 CX One, Inc. Precious MetalsNon-Energy Minerals CX One, Inc. provides gold exploration services. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Pharand
| Sociétés | Poste | Fin |
|---|---|---|
C Level III, Inc.
 C Level III, Inc. Financial ConglomeratesFinance C Level III, Inc. operates as a capital pool company. Currently, the company is in the process of identification and evaluation of assets or businesses for acquisition with a view to complete a qualifying transaction. C Level III was founded on June 10, 2011 and is headquartered in Toronto, Canada. | Directeur Général | 09/12/2013 |
| NEVADA EXPLORATION INC. | Président | 27/02/2009 |
| Mistral Pharma, Inc. | Directeur/Membre du Conseil | 06/05/2008 |
Innovatech Montreal, Inc.
 Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Corporate Officer/Principal | 05/07/2007 |
Corautus Genetics, Inc.
 Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Corautus Genetics Inc. is a biopharmaceutical company, which manufactures gene therapy products for the treatment of cardiac and vascular disease & peripheral vascular disease. It is located in Atlanta, GA. | Directeur/Membre du Conseil | 07/06/2007 |
Formation de Daniel Pharand
| Concordia University | Undergraduate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEVADA EXPLORATION INC. | Non-Energy Minerals |
| CANADIAN OIL RECOVERY & REMEDIATION ENTERPRISES LTD. | Industrial Services |
| Entreprise privées | 12 |
|---|---|
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Corautus Genetics Inc. is a biopharmaceutical company, which manufactures gene therapy products for the treatment of cardiac and vascular disease & peripheral vascular disease. It is located in Atlanta, GA. | Health Technology |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Innovatech Montreal, Inc.
Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Finance |
Aurelian Resources, Inc.
 Aurelian Resources, Inc. Precious MetalsNon-Energy Minerals Aurelian Resources, Inc. explores mines for gold, silver, and base metals. The company is headquartered in Toronto, Canada. | Non-Energy Minerals |
| Mistral Pharma, Inc. | Health Technology |
Arura Pharma, Inc.
 Arura Pharma, Inc. Pharmaceuticals: MajorHealth Technology Arura Pharma, Inc. manufactured and distributed health and beauty products. It focused on acquiring and commercializing prescription drugs and medical devices in the oncology, wound care, and neurology sectors. The company was founded on October 31, 2005 and was headquartered in Longueuil, Canada. | Health Technology |
Cato BioVentures
 Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Finance |
Cancer Advances, Inc.
 Cancer Advances, Inc. BiotechnologyHealth Technology Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC. | Health Technology |
Hemodynamic Therapeutics, Inc.
 Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Health Technology |
C Level III, Inc.
C Level III, Inc. Financial ConglomeratesFinance C Level III, Inc. operates as a capital pool company. Currently, the company is in the process of identification and evaluation of assets or businesses for acquisition with a view to complete a qualifying transaction. C Level III was founded on June 10, 2011 and is headquartered in Toronto, Canada. | Finance |
CX One, Inc.
CX One, Inc. Precious MetalsNon-Energy Minerals CX One, Inc. provides gold exploration services. The company is headquartered in Toronto, Canada. | Non-Energy Minerals |
